Teicoplanin AptaPharma

GIF decision: Marketing suspension

What does this decision mean?

• Wstrzymanie w obrocie — The product has been temporarily suspended from circulation — sales are paused pending clarification, but it is not a full market recall.

The tested sample did not meet the specification for the parameter "contamination with particles visible to the naked eye"; in 2 out of 20 vials of powder one particle was detected in the reconstituted product, probably originating from the solvent. Potencjalne skutki: embolism after intravenous administration, thrombotic complications, inflammatory reactions.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

App Store Google Play

Risk Level

Critical

Notice Date

17.06.2026

What to do if you have this product?

A recall means the product may be unsafe. Here is what to do if you have it at home.

1

Do not eat or use the product

Stop using or consuming it immediately and keep it out of reach of children.
2

Check the batch number and expiry date

Compare the batch/lot number and the best-before or expiry date with the details in the alert — sometimes only specific batches are affected.
3

Return it to the shop

You can take the product back to the shop where you bought it. For a safety recall a refund is due even without a receipt.
4

Get help and report it

If you feel unwell after using the product, contact a doctor. You can also report the case to the relevant authority — GIS, GIF or UOKiK.

General guidance for recalled products in Poland. Always follow the specific instructions in the official alert and from the manufacturer or retailer.

Teicoplanin AptaPharma

What to do if you have this product?

Other Notices

Teicoplanin AptaPharma

Azaneson

Imuldosa

Loperamid APTEO MED

Tullex